Skip to main content

and
  1. No Access

    Article

    Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile

    I Del Giudice, G M Rigolin, S Raponi, L Cafforio, C Ilari, J Wang, M Bordyuh in Leukemia (2018)

  2. No Access

    Article

    Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

    The World Health Organization classification of myelodysplastic syndromes (MDS) is based on morphological evaluation of marrow dysplasia. We performed a systematic review of cytological and histological data f...

    M G Della Porta, E Travaglino, E Boveri, M Ponzoni, L Malcovati, E Papaemmanuil in Leukemia (2015)

  3. No Access

    Article

    Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays

    To better define the significance of proliferation centers (PCs), the morphological hallmark of chronic lymphocytic leukemia (CLL), lymph node biopsies taken from 183 patients were submitted to histopathologic...

    M Ciccone, C Agostinelli, G M Rigolin, P P Piccaluga, F Cavazzini, S Righi in Leukemia (2012)

  4. No Access

    Article

    Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes

    Circulating endothelial cells (CECs) are associated with neoangiogenesis in various malignant disorders. Using flow cytometry, we studied CECs in 128 patients with myelodysplastic syndrome (MDS). MDS patients ...

    M G Della Porta, L Malcovati, G M Rigolin, V Rosti, E Bonetti, E Travaglino in Leukemia (2008)

  5. No Access

    Article

    Chronic lymphocytic leukemia with 6q− shows distinct hematological features and intermediate prognosis

    Cytogenetic and fluorescence in situ hybridization studies were successfully performed in 217 chronic lymphocytic leukemia (CLL). In all, 13 patients with 6q21 deletion were identified and characterized in compar...

    A Cuneo, G M Rigolin, R Bigoni, C De Angeli, A Veronese, F Cavazzini, A Bardi in Leukemia (2004)

  6. No Access

    Article

    CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review

    The analysis of CD87 (urokinase-type plasminogen activator receptor – uPAR) expression has a potential role in the diagnostic or prognostic work-up of several hematological malignancies, particularly acute leu...

    M C Béné, G Castoldi, W Knapp, G M Rigolin, L Escribano, P Lemez, W-D Ludwig in Leukemia (2004)